vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Information Services Group Inc. (III). Click either name above to swap in a different company.

Information Services Group Inc. is the larger business by last-quarter revenue ($61.2M vs $45.1M, roughly 1.4× Amarin Corp plc). Information Services Group Inc. runs the higher net margin — 4.3% vs -23.3%, a 27.6% gap on every dollar of revenue. On growth, Amarin Corp plc posted the faster year-over-year revenue change (7.0% vs 5.9%). Over the past eight quarters, Information Services Group Inc.'s revenue compounded faster (-2.4% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...

AMRN vs III — Head-to-Head

Bigger by revenue
III
III
1.4× larger
III
$61.2M
$45.1M
AMRN
Growing faster (revenue YoY)
AMRN
AMRN
+1.1% gap
AMRN
7.0%
5.9%
III
Higher net margin
III
III
27.6% more per $
III
4.3%
-23.3%
AMRN
Faster 2-yr revenue CAGR
III
III
Annualised
III
-2.4%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
III
III
Revenue
$45.1M
$61.2M
Net Profit
$-10.5M
$2.6M
Gross Margin
44.8%
Operating Margin
35.5%
8.4%
Net Margin
-23.3%
4.3%
Revenue YoY
7.0%
5.9%
Net Profit YoY
33.0%
-14.1%
EPS (diluted)
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
III
III
Q1 26
$45.1M
Q4 25
$49.2M
$61.2M
Q3 25
$49.7M
$62.4M
Q2 25
$72.7M
$61.6M
Q1 25
$42.0M
$59.6M
Q4 24
$62.3M
$57.8M
Q3 24
$42.3M
$61.3M
Q2 24
$67.5M
$64.3M
Net Profit
AMRN
AMRN
III
III
Q1 26
$-10.5M
Q4 25
$-1.2M
$2.6M
Q3 25
$-7.7M
$3.1M
Q2 25
$-14.1M
$2.2M
Q1 25
$-15.7M
$1.5M
Q4 24
$-48.6M
$3.0M
Q3 24
$-25.1M
$1.1M
Q2 24
$1.5M
$2.0M
Gross Margin
AMRN
AMRN
III
III
Q1 26
Q4 25
47.1%
44.8%
Q3 25
44.7%
42.2%
Q2 25
69.2%
42.2%
Q1 25
59.8%
43.1%
Q4 24
-15.4%
41.5%
Q3 24
38.5%
40.4%
Q2 24
63.4%
39.5%
Operating Margin
AMRN
AMRN
III
III
Q1 26
35.5%
Q4 25
-12.9%
8.4%
Q3 25
-22.4%
7.4%
Q2 25
-22.0%
7.6%
Q1 25
-39.9%
5.7%
Q4 24
-84.3%
0.3%
Q3 24
-59.5%
7.0%
Q2 24
-0.8%
5.7%
Net Margin
AMRN
AMRN
III
III
Q1 26
-23.3%
Q4 25
-2.5%
4.3%
Q3 25
-15.6%
4.9%
Q2 25
-19.4%
3.5%
Q1 25
-37.4%
2.5%
Q4 24
-78.0%
5.3%
Q3 24
-59.4%
1.9%
Q2 24
2.3%
3.2%
EPS (diluted)
AMRN
AMRN
III
III
Q1 26
Q4 25
$0.00
$0.06
Q3 25
$-0.02
$0.06
Q2 25
$-0.03
$0.04
Q1 25
$-0.04
$0.03
Q4 24
$-0.12
$0.07
Q3 24
$-0.06
$0.02
Q2 24
$0.00
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
III
III
Cash + ST InvestmentsLiquidity on hand
$307.8M
$28.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$94.7M
Total Assets
$645.8M
$211.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
III
III
Q1 26
$307.8M
Q4 25
$302.6M
$28.7M
Q3 25
$286.6M
$28.7M
Q2 25
$298.7M
$25.2M
Q1 25
$281.8M
$20.1M
Q4 24
$294.2M
$23.1M
Q3 24
$305.7M
$9.7M
Q2 24
$306.7M
$11.8M
Stockholders' Equity
AMRN
AMRN
III
III
Q1 26
Q4 25
$459.3M
$94.7M
Q3 25
$458.9M
$94.7M
Q2 25
$464.9M
$94.1M
Q1 25
$473.7M
$95.0M
Q4 24
$486.2M
$96.3M
Q3 24
$531.4M
$96.6M
Q2 24
$551.9M
$95.5M
Total Assets
AMRN
AMRN
III
III
Q1 26
$645.8M
Q4 25
$670.8M
$211.0M
Q3 25
$659.8M
$213.3M
Q2 25
$670.1M
$200.7M
Q1 25
$655.7M
$202.4M
Q4 24
$685.3M
$204.5M
Q3 24
$750.6M
$227.1M
Q2 24
$799.9M
$235.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
III
III
Operating Cash FlowLast quarter
$5.1M
Free Cash FlowOCF − Capex
$4.3M
FCF MarginFCF / Revenue
7.0%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
1.94×
TTM Free Cash FlowTrailing 4 quarters
$25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
III
III
Q1 26
Q4 25
$15.3M
$5.1M
Q3 25
$-12.7M
$11.1M
Q2 25
$16.6M
$11.9M
Q1 25
$-12.5M
$978.0K
Q4 24
$-13.3M
$6.6M
Q3 24
$-2.4M
$8.8M
Q2 24
$-2.7M
$2.2M
Free Cash Flow
AMRN
AMRN
III
III
Q1 26
Q4 25
$4.3M
Q3 25
$9.5M
Q2 25
$11.1M
Q1 25
$141.0K
Q4 24
$6.0M
Q3 24
$8.4M
Q2 24
$1.3M
FCF Margin
AMRN
AMRN
III
III
Q1 26
Q4 25
7.0%
Q3 25
15.2%
Q2 25
18.0%
Q1 25
0.2%
Q4 24
10.4%
Q3 24
13.7%
Q2 24
2.0%
Capex Intensity
AMRN
AMRN
III
III
Q1 26
Q4 25
1.2%
Q3 25
2.5%
Q2 25
1.4%
Q1 25
1.4%
Q4 24
0.9%
Q3 24
0.6%
Q2 24
1.4%
Cash Conversion
AMRN
AMRN
III
III
Q1 26
Q4 25
1.94×
Q3 25
3.62×
Q2 25
5.46×
Q1 25
0.66×
Q4 24
2.15×
Q3 24
7.66×
Q2 24
-1.81×
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

III
III

Segment breakdown not available.

Related Comparisons